Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Clin Radiol ; 79(2): e295-e304, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38030506

ABSTRACT

AIM: To investigate peripheral and central olfactory pathways using cranial magnetic resonance imaging (MRI) in human immunodeficiency virus (HIV)-infected patients. MATERIALS AND METHODS: The cranial MRI images of 37 HIV-infected adult patients and 37 adults without HIV infection having normal cranial MRI results were included in the study. In both groups, olfactory bulb (OB) volume and olfactory sulcus (OS) depth; and insular gyrus and corpus amygdala areas were measured using cranial MRI. In the HIV group, disease duration, HIV RNA, and CD4 lymphocyte count and levels as a percentage were also recorded. RESULTS: The HIV group had significantly lower bilateral OB volumes, insular gyrus and corpus amygdala areas compared to the control group. The HIV group showed positive correlations between OB volumes, OS depths, insular gyrus, and corpus amygdala areas bilaterally. Increases in OB volumes and OS depths were associated with an increase in the insular gyrus area. The corpus amygdala and insular gyrus areas increased similarly. There was no significant correlation between age, gender, disease duration, CD4 lymphocyte count and per cent, HIV RNA values, and the measurement values of the central and peripheral olfactory regions. CONCLUSION: A decrease in olfactory regions of OB, insular gyrus, and corpus amygdala in HIV-infected patients shows that HIV infection may cause olfactory impairment. There is no correlation between disease duration and olfactory impairment. It may be related to neuroinflammation, HIV-related brain atrophy, acquired immunodeficiency syndrome (AIDS) dementia complex, or neurocognitive impairment, which are the other explanations for the olfactory impairment in HIV. The possible toxicity from antiretroviral therapy (ART) may be another cause that should be investigated further.


Subject(s)
HIV Infections , Olfaction Disorders , Adult , Humans , HIV , Olfactory Pathways , HIV Infections/complications , Magnetic Resonance Imaging/adverse effects , Olfaction Disorders/etiology , RNA
2.
Curr HIV Res ; 18(4): 258-266, 2020.
Article in English | MEDLINE | ID: mdl-32342820

ABSTRACT

OBJECTIVE: The aim of this study was to analyze the temporal trends of HIV epidemiology in Turkey from 2011 to 2016. METHODS: Thirty-four teams from 28 centers at 17 different cities participated in this retrospective study. Participating centers were asked to complete a structured form containing questions about epidemiologic, demographic and clinical characteristics of patients presented with new HIV diagnosis between 2011 and 2016. Demographic data from all centers (complete or partial) were included in the analyses. For the cascade of care analysis, 15 centers that provided full data from 2011 to 2016 were included. Overall and annual distributions of the data were calculated as percentages and the Chi square test was used to determine temporal changes. RESULTS: A total of 2,953 patients between 2011 and 2016 were included. Overall male to female ratio was 5:1 with a significant increase in the number of male cases from 2011 to 2016 (p<0.001). The highest prevalence was among those aged 25-34 years followed by the 35-44 age bracket. The most common reason for HIV testing was illness (35%). While the frequency of sex among men who have sex with men increased from 16% to 30.6% (p<0.001) over the study period, heterosexual intercourse (53%) was found to be the most common transmission route. Overall, 29% of the cases presented with a CD4 count of >500 cells/mm3 while 46.7% presented with a CD4 T cell count of <350 cells/mm3. Among newly diagnosed cases, 79% were retained in care, and all such cases initiated ART with 73% achieving viral suppression after six months of antiretroviral therapy. CONCLUSION: The epidemiologic profile of HIV infected individuals is changing rapidly in Turkey with an increasing trend in the number of newly diagnosed people disclosing themselves as MSM. New diagnoses were mostly at a young age. The late diagnosis was found to be a challenging issue. Despite the unavailability of data for the first 90, Turkey is close to the last two steps of 90-90-90 targets.


Subject(s)
HIV Infections/epidemiology , HIV/pathogenicity , Hepacivirus/pathogenicity , Hepatitis B virus/pathogenicity , Hepatitis B/epidemiology , Hepatitis C/epidemiology , Adolescent , Adult , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/virology , Child , Child, Preschool , Coinfection , Delayed Diagnosis , Female , HIV/drug effects , HIV/physiology , HIV Infections/drug therapy , HIV Infections/mortality , HIV Infections/virology , Hepacivirus/drug effects , Hepacivirus/physiology , Hepatitis B/drug therapy , Hepatitis B/mortality , Hepatitis B/virology , Hepatitis B virus/drug effects , Hepatitis B virus/physiology , Hepatitis C/drug therapy , Hepatitis C/mortality , Hepatitis C/virology , Heterosexuality/statistics & numerical data , Homosexuality, Male/statistics & numerical data , Humans , Incidence , Infant , Male , Middle Aged , Retrospective Studies , Survival Analysis , Turkey/epidemiology , Viral Load/drug effects
3.
J Hosp Infect ; 98(3): 260-263, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29248504

ABSTRACT

This article describes the emergence of resistance and predictors of fatality for 1556 cases of healthcare-associated Gram-negative bloodstream infection in 2014 and 2015. The colistin resistance rate in Klebsiella pneumoniae was 16.1%, compared with 6% in 2013. In total, 660 (42.4%) cases were fatal. The highest fatality rate was among patients with Acinetobacter baumannii bacteraemia (58%), followed by Pseudomonas aeruginosa (45%), Klebsiella pneumoniae (41%), Enterobacter cloacae (32%) and Escherichia coli (28%). On multi-variate analysis, the minimum inhibitory concentrations for carbapenems [odds ratio (OR) 1.02, 95% confidence interval (CI) 1.01-1.04; P = 0.002] and colistin (OR 1.1, 95% CI 1.03-1.17; P = 0.001) were found to be significantly associated with fatality.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteremia/mortality , Colistin/pharmacology , Cross Infection/mortality , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/mortality , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Carbapenems/pharmacology , Cross Infection/microbiology , Female , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies
4.
J Hosp Infect ; 94(4): 381-385, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27717604

ABSTRACT

This article describes the prevalence of antibiotic resistance and predictors of mortality for healthcare-associated (HA) Gram-negative bloodstream infections (GN-BSI). In total, 831 cases of HA GN-BSI from 17 intensive care units in different centres in Turkey were included; the all-cause mortality rate was 44%. Carbapenem resistance in Klebsiella pneumoniae was 38%, and the colistin resistance rate was 6%. Multi-variate analysis showed that age >70 years [odds ratio (OR) 2, 95% confidence interval (CI) 1.22-3.51], central venous catheter use (OR 2.1, 95% CI 1.09-4.07), ventilator-associated pneumonia (OR 1.9, 95% CI 1.1-3.16), carbapenem resistance (OR 1.8, 95% CI 1.11-2.95) and APACHE II score (OR 1.1, 95% CI 1.07-1.13) were significantly associated with mortality.


Subject(s)
Bacteremia/mortality , Cross Infection/mortality , Drug Resistance, Bacterial , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/mortality , Adult , Aged , Bacteremia/epidemiology , Bacteremia/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Female , Gram-Negative Bacteria/classification , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Humans , Intensive Care Units , Male , Middle Aged , Prevalence , Prognosis , Retrospective Studies , Risk Factors , Survival Analysis , Turkey/epidemiology
5.
HIV Clin Trials ; 17(3): 109-13, 2016 05.
Article in English | MEDLINE | ID: mdl-27125365

ABSTRACT

OBJECTIVES: Integrase strand transfer inhibitor (INSTI) is a new class of antiretroviral (ARV) drugs designed to block the action of the integrase viral enzyme, which is responsible for insertation of the HIV-1 genome into the host DNA. The aim of this study was to evaluate for the first time INSTI resistance mutations in Turkish patients. METHODS: This study was conducted in Turkey, between April 2013 and April 2015 using 169 HIV-1-infected patients (78 ARV naive patients and 91 ARV-experienced patients). Laboratory and clinical characteristics of ARV naive and ARV-experienced patients were as follows: gender (M/F): 71/7 and 80/11, median age: 38 and 38.4; median CD4(+) T-cell: 236 and 216 cells/mm(3), median HIV-1 RNA: 4.95+E5 and 1.08E+6 copies/ml. Population-based seqeunces of the reverse transcriptase, protease, and integrase domains of the HIV-1 pol gene were used to detect HIV-1 drug resistance mutations. RESULT: INSTI resistance mutations were not found in recently diagnosed HIV-1-infected patients. However, ARV-experienced patients had major resistance mutations associated with raltegravir and elvitegravir; the following results were generated:F121Y, Y143R, Q148R and E157Q (6/91 - 6.6%). CONCLUSIONS: The prevalence of INSTI resistant mutations in ART-experienced patients suggested that resistance testing must be incorporated as an integral part of HIV management with INSTI therapies.


Subject(s)
Drug Resistance, Viral , HIV Infections/drug therapy , HIV Infections/virology , HIV Integrase Inhibitors/therapeutic use , HIV-1/drug effects , HIV-1/genetics , Mutation , Adult , Aged , Amino Acid Substitution , CD4 Lymphocyte Count , Codon , Coinfection , Female , Genotype , HIV Infections/transmission , HIV Integrase Inhibitors/pharmacology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , RNA, Viral , Risk Factors , Turkey , Viral Load , Young Adult
6.
Clin Microbiol Infect ; 19(2): E80-6, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23210984

ABSTRACT

No detailed data exist in the literature on the accurate diagnosis of chronic brucellar meningitis or meningoencephalitis. A multicentre retrospective chart review was performed at 19 health centres to determine sensitivities of the diagnostic tests. This study included 177 patients. The mean values of CSF biochemical test results were as follows: CSF protein, 330.64 ± 493.28 mg/dL; CSF/ blood-glucose ratio, 0.35 ± 0.16; CSF sodium, 140.61 ± 8.14 mMt; CSF leucocyte count, 215.99 ± 306.87. The sensitivities of the tests were as follows: serum standard tube agglutination (STA), 94%; cerebrospinal fluid (CSF) STA, 78%; serum Rose Bengal test (RBT), 96%; CSF RBT, 71%; automated blood culture, 37%; automated CSF culture, 25%; conventional CSF culture, 9%. The clinician should use every possible means to diagnose chronic neurobrucellosis. The high seropositivitiy in brucellar blood tests must facilitate the use of blood serology. Although STA should be preferred over RBT in CSF in probable neurobrucellosis other than the acute form of the disease, RBT is not as weak as expected. Moreover, automated culture systems should be applied when CSF culture is needed.


Subject(s)
Brucellosis/diagnosis , Clinical Laboratory Techniques/methods , Meningitis, Bacterial/diagnosis , Adolescent , Adult , Aged , Brucellosis/microbiology , Cerebrospinal Fluid/chemistry , Cerebrospinal Fluid/cytology , Chronic Disease , Female , Humans , Male , Meningitis, Bacterial/microbiology , Middle Aged , Sensitivity and Specificity , Serum/chemistry , Young Adult
7.
Asian Pac J Trop Biomed ; 1(6): 478-81, 2011 Dec.
Article in English | MEDLINE | ID: mdl-23569817

ABSTRACT

OBJECTIVE: To determine the level of oxygen-nitrogen stress parameters in the pathogenesis of amebiasis. METHODS: Twenty-four acute intestinal amebiasis patients and 20 healthy controls were enrolled in the present study. Serum malondialdehyde and nitric oxide levels were determined spectrophotometrically. RESULTS: Serum malondialdehyde and nitric oxide levels were significantly higher in acute intestinal amebiasis patients than healthy controls (P<0.001). CONCLUSIONS: These results suggest that oxidative and nitrosative stress may play a major role in tissue damage in acute intestinal amebiasis patients. Also these parameters can be used to supplement the conventional microscopic method for reliable diagnosis of intestinal amebiasis.


Subject(s)
Dysentery, Amebic/pathology , Malondialdehyde/blood , Nitric Oxide/blood , Serum/chemistry , Adolescent , Adult , Biomarkers/blood , Dysentery, Amebic/diagnosis , Female , Humans , Male , Middle Aged , Spectrophotometry , Young Adult
8.
Rheumatol Int ; 30(4): 515-7, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19536545

ABSTRACT

The objective of this study is to investigate rheumatologic manifestations of hepatitis B and C and their relation with viral load and degree of hepatic fibrosis. Thirty-six HBV and 36 HBV patients were included. Liver biopsy was performed for all participants. We detected arthralgia 53-50%, myalgia 58-61% and fatigue 64-81% in HBV and HCV groups in order. All manifestations did not differ between groups significantly. Pain intensity was higher in HCV group (P = 0.023). Arthralgia is associated with viral load of the patients in both groups (P = 0.000 and P = 0.001). Viral load and fatigue are correlated in both groups (P = 0.000 and P = 0.001). There is a considerable relation between inflammation and arthralgia (P = 0.000) and myalgia (P = 0.033). We conclude that rheumatologic manifestations are common both in HBV and HCV and related with viral load and fibrosis.


Subject(s)
Arthralgia/physiopathology , Hepatitis B, Chronic/physiopathology , Hepatitis C, Chronic/physiopathology , Liver Cirrhosis/physiopathology , Rheumatic Diseases/physiopathology , Adult , Arthralgia/pathology , Arthralgia/virology , Biopsy , Disability Evaluation , Fatigue/pathology , Fatigue/physiopathology , Fatigue/virology , Female , Hepatitis B, Chronic/complications , Hepatitis B, Chronic/pathology , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/pathology , Humans , Joints/physiopathology , Liver/pathology , Liver/virology , Liver Cirrhosis/pathology , Liver Cirrhosis/virology , Male , Muscular Diseases/pathology , Muscular Diseases/physiopathology , Muscular Diseases/virology , Pain/pathology , Pain/physiopathology , Pain/virology , Pain Measurement , Quality of Life , Rheumatic Diseases/pathology , Rheumatic Diseases/virology , Viral Load
9.
Int J Lab Hematol ; 29(6): 442-5, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17988299

ABSTRACT

Brucellosis continues to be an important cause of fever in underdeveloped countries and in rural areas of developed world. It is a multisystemic disease, associated with wide variety of symptoms. A wide variety of symptoms, including haematological abnormalities, such as anaemia, thrombocytopenia, pancytopenia, dissemine intravascular coagulation and leucopoenia could be seen, all of which are more common than usually thought. In this short study, we present a relatively uncommon haematological manifestation that of isolated thrombocytopenia mimicking idiopathic thrombocytopenic purpura, which we observed in seven of 114 patients who were diagnosed with brucellosis in our hospital over a 2-year period. Having given brucellosis treatment with rifampicin and doxycycline, complete remission was achieved and thrombocyte count returned to normal in all cases.


Subject(s)
Brucellosis/diagnosis , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Thrombocytopenia/diagnosis , Adult , Aged , Antibiotics, Antitubercular/administration & dosage , Brucellosis/drug therapy , Diagnosis, Differential , Doxycycline/administration & dosage , Female , Humans , Male , Middle Aged , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Rifampin/administration & dosage , Thrombocytopenia/drug therapy
10.
J Int Med Res ; 32(1): 78-83, 2004.
Article in English | MEDLINE | ID: mdl-14997711

ABSTRACT

Ventilator-associated pneumonia (VAP) is the most common infection in intensive care units. It is caused by prolonged hospitalization and results in high mortality rates. This retrospective clinical study, of 140 patients in a surgical intensive care unit, aimed to identify the bacterial agents responsible for VAP infection, and determine antibiotic resistance rates in VAP. Antibiotic sensitivity was evaluated by culturing and testing tracheal aspirates from patients with clinical and radiological findings of VAP. The bacteria isolated most frequently were Pseudomonas aeruginosa (33.9%), Staphylococcus aureus (30.0%), Acinetobacter baumannii (26.1%), and Enterobacter species (4.3%). A. baumannii was more prevalent than in previous years. The results of antibiotic sensitivity testing suggested sulbactam/cefoperazone as the most appropriate drug for treating these patients. We suggest, however, that when staphylococcal pneumonia is suspected, a glycopeptide (vancomycin or teicoplanin) or combined trimethoprim-sulfamethoxazole is used as first-line therapy until sensitivity results are obtained. In conclusion, development of antibiotic policies for individual hospitals can reduce high antibiotic resistance rates due to VAP.


Subject(s)
Critical Care , Drug Resistance , Intensive Care Units , Pneumonia, Bacterial/drug therapy , Respiration, Artificial/adverse effects , Anti-Bacterial Agents/classification , Anti-Bacterial Agents/therapeutic use , Humans , Microbial Sensitivity Tests , Pneumonia, Bacterial/etiology
11.
Int J Clin Pract ; 57(8): 735-6, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14627189

ABSTRACT

We present a case of septicaemia, pneumonia and meningitis due to Streptococcus bovis type-II in a patient who had undergone a total hip prosthesis under general anaesthesia three weeks earlier. This organism is an uncommon human pathogen that sometimes causes bacteraemia and endocarditis and is usually connected with colon pathology and dental procedures. In the reported case, there were no risk factors for S. bovis infection except for the hip operation. S. bovis type II sensitive to penicillin was isolated from all blood and pleural fluid cultures. The patient recovered and was discharged from hospital two weeks after presentation.


Subject(s)
Meningitis, Bacterial/microbiology , Pneumonia, Bacterial , Sepsis/microbiology , Streptococcal Infections , Streptococcus bovis , Aged , Hip Prosthesis/adverse effects , Hip Prosthesis/microbiology , Humans , Male , Prosthesis-Related Infections/complications , Treatment Outcome
12.
Int J Clin Pract ; 57(1): 20-4, 2003.
Article in English | MEDLINE | ID: mdl-12587937

ABSTRACT

This prospective study was carried out in the department of infectious diseases of Gaziantep University between January 1997 and December 1999 to evaluate the epidemiological, clinical and laboratory features of brucellosis in south-eastern Turkey. One hundred and twenty consecutive patients with active brucellosis were enrolled. The commonest way of transmission was ingestion of milk products from diseased animals. Brucella melitensis was isolated in the specimens of 31 (45.5%) of 68 patients. The commonest abnormalities on physical examination were fever (66.6%), hepatomegaly (63.3%) and splenomegaly (56.6%). Osteoarticular involvement was found in 34 patients (28.3%). Fifteen (12.5%) patients had ocular involvement. Hepatitis, orchiepididymitis, pulmonary involvement and meningitis were found in one (0.8%), four (6.8%), three (2.5%) and one (0.8) patient, respectively. The commonest haematological abnormalities were relative lymphomonocytosis (71.6%) and anaemia (36.6%). In conclusion, brucellosis continues to be a common health problem in communities where the consumption of unpasteurised dairy products is common. Since prevention is as important as early diagnosis in reducing the morbidity of brucellosis, we suggest that improving current health policies with additional educational programmes is essential.


Subject(s)
Brucellosis/epidemiology , Dairy Products/adverse effects , Adolescent , Adult , Blood Cell Count/methods , Brucellosis/blood , Brucellosis/microbiology , Female , Humans , Male , Middle Aged , Prospective Studies , Turkey/epidemiology
13.
Int J Clin Pract ; 57(10): 919-20, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14712899

ABSTRACT

We report the case of a 14-year-old girl with Guillain-Barré syndrome associated with brucellosis due to Brucella melitensis. The diagnosis was established by the isolation of B. melitensis from her blood and by the determination of high levels of Brucella aglutinins in her sera and cerebrospinal fluid. A combination of rifampin, co-trimoxazole and physical therapy resulted in complete healing within 30 days. Antibrucellar treatment continued for 12 weeks. This case report suggests that brucellosis should be kept in mind in the aetiology of Guillain-Barré syndrome in the endemic areas for brucellosis, and bacteriological and serological tests for brucellosis should be performed.


Subject(s)
Brucellosis/complications , Guillain-Barre Syndrome/complications , Adolescent , Anti-Infective Agents/therapeutic use , Antibiotics, Antitubercular/therapeutic use , Brucella melitensis , Brucellosis/therapy , Drug Combinations , Female , Guillain-Barre Syndrome/therapy , Humans , Physical Therapy Modalities , Rifampin/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...